Report Detail

Other Global Pruritus Therapeutics Market Size, Status and Forecast 2019-2025

  • RnM3074273
  • |
  • 08 March, 2019
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Other

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
Skin disease is the fourth leading cause of nonfatal disease burden. Skin diseases include eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and other bacterial skin diseases, cellulitis, viral warts, molluscum contagiosum, and non-melanoma skin cancer. Among these types, fungal skin diseases and pruritus were in the top 10 most prevalent diseases worldwide in 2010. Thus pruritus therapeutics market is growing with rising prevalence of skin diseases. Moreover, patent expiration of dermatitis drugs and the introduction of new products are also responsible for the growth of pruritus therapeutics market.
The classification of Pruritus Therapeutics includes Corticosteroids, Antihistamines, Calcineurin Inhibitors and other. The proportion of Antihistamines in 2016 is about 21.6%, and the proportion of Corticosteroids is about 22.9%.
North America is the largest consumption place, with a revenue market share nearly 43.4% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 27.3%.
In 2018, the global Pruritus Therapeutics market size was 11300 million US$ and it is expected to reach 16700 million US$ by the end of 2025, with a CAGR of 5.0% during 2019-2025.

This report focuses on the global Pruritus Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pruritus Therapeutics development in United States, Europe and China.

The key players covered in this study
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont

Market segment by Type, the product can be split into
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Other

Market segment by Application, split into
External Use
Oral
Injection

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pruritus Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Pruritus Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pruritus Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pruritus Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Antihistamines
      • 1.4.3 Corticosteroids
      • 1.4.4 Calcineurin Inhibitors
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Pruritus Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 External Use
      • 1.5.3 Oral
      • 1.5.4 Injection
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pruritus Therapeutics Market Size
    • 2.2 Pruritus Therapeutics Growth Trends by Regions
      • 2.2.1 Pruritus Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Pruritus Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Pruritus Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Pruritus Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Pruritus Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Pruritus Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pruritus Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Pruritus Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Pruritus Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pruritus Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Pruritus Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pruritus Therapeutics Market Size (2014-2019)
    • 5.2 Pruritus Therapeutics Key Players in United States
    • 5.3 United States Pruritus Therapeutics Market Size by Type
    • 5.4 United States Pruritus Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Pruritus Therapeutics Market Size (2014-2019)
    • 6.2 Pruritus Therapeutics Key Players in Europe
    • 6.3 Europe Pruritus Therapeutics Market Size by Type
    • 6.4 Europe Pruritus Therapeutics Market Size by Application

    7 China

    • 7.1 China Pruritus Therapeutics Market Size (2014-2019)
    • 7.2 Pruritus Therapeutics Key Players in China
    • 7.3 China Pruritus Therapeutics Market Size by Type
    • 7.4 China Pruritus Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Pruritus Therapeutics Market Size (2014-2019)
    • 8.2 Pruritus Therapeutics Key Players in Japan
    • 8.3 Japan Pruritus Therapeutics Market Size by Type
    • 8.4 Japan Pruritus Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pruritus Therapeutics Market Size (2014-2019)
    • 9.2 Pruritus Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Pruritus Therapeutics Market Size by Type
    • 9.4 Southeast Asia Pruritus Therapeutics Market Size by Application

    10 India

    • 10.1 India Pruritus Therapeutics Market Size (2014-2019)
    • 10.2 Pruritus Therapeutics Key Players in India
    • 10.3 India Pruritus Therapeutics Market Size by Type
    • 10.4 India Pruritus Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pruritus Therapeutics Market Size (2014-2019)
    • 11.2 Pruritus Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Pruritus Therapeutics Market Size by Type
    • 11.4 Central & South America Pruritus Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 J&J
      • 12.1.1 J&J Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pruritus Therapeutics Introduction
      • 12.1.4 J&J Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.1.5 J&J Recent Development
    • 12.2 Abbott
      • 12.2.1 Abbott Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pruritus Therapeutics Introduction
      • 12.2.4 Abbott Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.2.5 Abbott Recent Development
    • 12.3 Amgen
      • 12.3.1 Amgen Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pruritus Therapeutics Introduction
      • 12.3.4 Amgen Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.3.5 Amgen Recent Development
    • 12.4 LEO Pharma
      • 12.4.1 LEO Pharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pruritus Therapeutics Introduction
      • 12.4.4 LEO Pharma Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.4.5 LEO Pharma Recent Development
    • 12.5 Novartis
      • 12.5.1 Novartis Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pruritus Therapeutics Introduction
      • 12.5.4 Novartis Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.5.5 Novartis Recent Development
    • 12.6 Bayer
      • 12.6.1 Bayer Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pruritus Therapeutics Introduction
      • 12.6.4 Bayer Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.6.5 Bayer Recent Development
    • 12.7 Pfizer
      • 12.7.1 Pfizer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pruritus Therapeutics Introduction
      • 12.7.4 Pfizer Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.7.5 Pfizer Recent Development
    • 12.8 UCB Pharma
      • 12.8.1 UCB Pharma Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pruritus Therapeutics Introduction
      • 12.8.4 UCB Pharma Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.8.5 UCB Pharma Recent Development
    • 12.9 GlaxoSmithKline
      • 12.9.1 GlaxoSmithKline Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Pruritus Therapeutics Introduction
      • 12.9.4 GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.9.5 GlaxoSmithKline Recent Development
    • 12.10 Galderma
      • 12.10.1 Galderma Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Pruritus Therapeutics Introduction
      • 12.10.4 Galderma Revenue in Pruritus Therapeutics Business (2014-2019)
      • 12.10.5 Galderma Recent Development
    • 12.11 Huapont

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Pruritus Therapeutics. Industry analysis & Market Report on Pruritus Therapeutics is a syndicated market report, published as Global Pruritus Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Pruritus Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,108.30
      4,662.45
      6,216.60
      3,623.10
      5,434.65
      7,246.20
      596,427.00
      894,640.50
      1,192,854.00
      325,338.00
      488,007.00
      650,676.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report